Follicular Lymphoma Global Clinical Trials Review, H2, 2017

  • ID: 4396655
  • Clinical Trials
  • Region: Global
  • 750 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • Bayer AG
  • Celgene Corp
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences Inc
  • MORE
Follicular Lymphoma Global Clinical Trials Review, H2, 2017

Summary

The clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Follicular Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Follicular Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the author’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Amgen Inc
  • Bayer AG
  • Celgene Corp
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences Inc
  • MORE
Report Guidance
Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Follicular Lymphoma to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Follicular Lymphoma to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Follicular Lymphoma Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Follicular Lymphoma
Aug 07, 2017: Kite Announces Initiation of Axicabtagene Ciloleucel CAR-T Clinical Program in the European Union
Jun 24, 2017: Verastem Reports Phase 2 Long-Term Follow-Up Data for Duvelisib in Patients with Double-Refractory Follicular Lymphoma and Small Lymphocytic Lymphoma at the 22nd Congress of the European Hematology Association
Jun 23, 2017: Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma
Jun 17, 2017: Updated Data from Phase IIIb MAGNIFY Study of REVLIMID (lenalidomide) and Rituximab Combination (R2) Show Clinical Activity and Responses in Relapsed/Refractory Follicular and Marginal Zone Lymphoma
Jun 16, 2017: BeiGene Presents Initial Phase 1 Data on BTK Inhibitor BGB-3111 Combined with Obinutuzumab at the 14th International Conference on Malignant Lymphoma and Announces Additional Planned Global Registrational Trials for BGB-3111
Jun 15, 2017: TG Therapeutics Announces Follow-Up Data from the Triple Combination of TG-1101, TGR-1202, and Bendamustine in Patients with DLBCL and FL at the 14th International Conference on Malignant Lymphoma
Jun 14, 2017: Celltrion Healthcare showcases data supporting the efficacy and safety of Truxima (CT-P10, biosimilar rituximab) in advanced follicular lymphoma and rheumatoid arthritis
Jun 14, 2017: Epizyme Reports Positive Interim Data from Phase 2 Trial for Tazemetostat in Relapsed or Refractory Follicular Lymphoma and DLBCL Patients
Jun 13, 2017: TG Therapeutics Recaps Schedule of Clinical Data Presentations of TGR-1202 at the Upcoming 14th International Conference on Malignant Lymphoma & the 22nd European Hematology Association Annual Congress
Jun 07, 2017: BeiGene to Present Data on BGB-3111 at the 14th International Conference on Malignant Lymphoma and to Host Conference Call
Jun 05, 2017: Immune Design Updates Positive Data from Lead Immuno-oncology Product candidate, G100, at ASCO Annual Meeting
May 31, 2017: MEI Pharma Announces Pre-Specified Response Rate Exceeded in Dose-Escalation Study of ME-401 in Chronic Lymphocytic Leukemia and Follicular Lymphoma
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About
Contact
Disclaimer
Source

List of Tables
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Region, 2017*
Follicular Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017*
Proportion of Follicular Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2017*
Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Follicular Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2017*
Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2017*
Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2017*
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

List of Figures
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2017*
Follicular Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*
Follicular Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017*
Proportion of Follicular Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2017*
Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Follicular Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Follicular Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2017*
Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Follicular Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2017*
Follicular Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*
Follicular Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Follicular Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • F. Hoffmann-La Roche Ltd
  • Celgene Corp
  • AbbVie Inc
  • Johnson & Johnson
  • GlaxoSmithKline Plc
  • Takeda Pharmaceutical Company Ltd
  • Novartis AG
  • Gilead Sciences Inc
  • Amgen Inc
  • Bayer AG
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll